Anti-HLA G antibody [MEM-G/9]
| Name | Anti-HLA G antibody [MEM-G/9] |
|---|---|
| Supplier | Abcam |
| Catalog | ab7758 |
| Prices | $397.00 |
| Sizes | 100 µg |
| Host | Mouse |
| Clonality | Monoclonal |
| Isotype | IgG1 |
| Clone | MEM-G/9 |
| Applications | ICC/IF ICC/IF IHC-F WB ELISA FC |
| Species Reactivities | Human, Primate |
| Antigen | Recombinant full length protein (Human) |
| Description | Mouse Monoclonal |
| Gene | HLA-G |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
ab7758 staining HLA G in Human JEG-3 cells by Flow Cytometry. The sample was incubated with the primary antibody, (1/50), for 1 hour. Ab6785(1/100) was used as secondary antibody.Gating Strategy: Isotrope controlSee Abreview
ab7758 staining HLA G in Human JEG-3 cells by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were blocked with 10% serum for 45 minutes at 24°C. Samples were incubated with primary antibody (1/50) for 1 hour at 24°C. Ab6785 (1/100) was used as the secondary antibody.See Abreview
Product References
Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-gamma responses to - Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-gamma responses to
Le Page ME, Goodridge JP, John E, Christiansen FT, Witt CS. J Immunol. 2014 Jan 15;192(2):732-40.
Impact of the NK cell receptor LIR-1 (ILT-2/CD85j/LILRB1) on cytotoxicity against - Impact of the NK cell receptor LIR-1 (ILT-2/CD85j/LILRB1) on cytotoxicity against
Heidenreich S, Zu Eulenburg C, Hildebrandt Y, Stubig T, Sierich H, Badbaran A, Eiermann TH, Binder TM, Kroger N. Clin Dev Immunol. 2012;2012:652130.
Reassessment of HLA-G isoform specificity of MEM-G/9 and 4H84 monoclonal - Reassessment of HLA-G isoform specificity of MEM-G/9 and 4H84 monoclonal
Zhao L, Teklemariam T, Hantash BM. Tissue Antigens. 2012 Sep;80(3):231-8.
MT1-MMP expression in first-trimester placental tissue is upregulated in type 1 - MT1-MMP expression in first-trimester placental tissue is upregulated in type 1
Hiden U, Glitzner E, Ivanisevic M, Djelmis J, Wadsack C, Lang U, Desoye G. Diabetes. 2008 Jan;57(1):150-7. Epub 2007 Oct 10.
Villous explant culture using early gestation tissue from ongoing pregnancies - Villous explant culture using early gestation tissue from ongoing pregnancies
Seeho SK, Park JH, Rowe J, Morris JM, Gallery ED. Hum Reprod. 2008 May;23(5):1170-9.
Natural-killer cell ligands at the maternal-fetal interface: UL-16 binding - Natural-killer cell ligands at the maternal-fetal interface: UL-16 binding
Apps R, Gardner L, Traherne J, Male V, Moffett A. Hum Reprod. 2008 Nov;23(11):2535-48.
Regulatory role of tryptophan degradation pathway in HLA-G expression by human - Regulatory role of tryptophan degradation pathway in HLA-G expression by human
Lopez AS, Alegre E, LeMaoult J, Carosella E, Gonzalez A. Mol Immunol. 2006 Jul;43(14):2151-60. Epub 2006 Feb 21.
Difference in gene expression between human fetal liver and adult bone marrow - Difference in gene expression between human fetal liver and adult bone marrow
Gotherstrom C, West A, Liden J, Uzunel M, Lahesmaa R, Le Blanc K. Haematologica. 2005 Aug;90(8):1017-26.
Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools - Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools
Menier C, Saez B, Horejsi V, Martinozzi S, Krawice-Radanne I, Bruel S, Le Danff C, Reboul M, Hilgert I, Rabreau M, Larrad ML, Pla M, Carosella ED, Rouas-Freiss N. Hum Immunol. 2003 Mar;64(3):315-26.